Inhibition of Both the Autocrine and the Paracrine Growth of Human Leukemia with a Fully Human Antibody Directed Against Vascular Endothelial Growth Factor Receptor 2

References

• Ferrara, N. (1999) "Molecular and biological properties of vascular endothelial growth factor", Journal of Molecular Medicine, 77, 527 — 543.
   Google Scholar
• Klagsbrum, M. and D'Amore, P.A. (1996) "Vascular endothelial growth factor and its receptors", Cytokine Growth Factor Review, 7, 259— 270.
   Google Scholar
• Neufeld, G., Cohen, T., Gengrinovitch, S. and Poltorak, Z. (1999) "Vascular endothelial growth factor (VEGF) and its receptors", FASEB Journal, 13, 9–22.
   Google Scholar
• Margolin, K. (2000) "Inhibition of vascular endothelial growth factor in the treatment of solid tumors", Curr. Oncol. Reports, 4, 20— 28.
   Google Scholar
• Zhu, Z., Bohlen, P. and Witte, L. (2002) "Clinical development of angiogenesis inhibitors to vascular endothelial growth factor and its receptors as cancer therapeutics", Current Cancer Drug Targets, 2, 135— 156.
   Google Scholar
• Zogakis, T.G. and Libutti, S.K. (2001) "General aspects of anti-angiogenesis and cancer therapy", Experts Opinion on Biological Therapy, 1, 253–275.
   Google Scholar
• Aguayo, A., Kantarjian, H., Manshouri, T., Gidel, C., Estey, E., Thomas, D., et al. (2000) "Angiogenesis in acute and chronic leukemias and myelodysplastic syndromes", Blood, 96, 2240— 2245.
   Google Scholar
• Perez-Atayde, AR., Sallan, SE., Tedrow, U., Connors, S., Allred, E. and Folkman, J. (1997) "Spectrum of tumor angiogenesis in the bone marrow of children with acute lymphoblastic leukemia", American Jpurnal of Pathology, 150, 815— 821.
   Google Scholar
• Vacca, A., Ribatti, D., Roncali, L., Ranieri, G., Serio, G., Silvestris, F., et al. (1994) "Bone marrow angiogenesis and progression in multiple myeloma", British Journal of Haematology, 87, 503–508.
   Google Scholar
• Pruneri, G., Bertolini, F., Soligo, D., Carboni, N., Cortelezzi, A., Ferrucci, P.F., et al. (1999) "Angiogenesis in myelodysplastic syndromes", British Journal of Cancer, 81, 1398 — 1401.
   Google Scholar
• Padro, T., Ruiz, S., Bieker, R., Burger, H., SteMs, M., Kienast, J., et al. (2000) "Increased angiogenesis in the bone marrow of patients with acute myeloid leukemia", Blood, 95, 2637— 2644.
   Google Scholar
• Hussong, J.W., Rodgers, G.M. and Shami, P.J. (2000) "Evidence of increased angiogenesis in patients with acute myeloid leukemia", Blood, 95, 309–313.
   Google Scholar
• Fiedler, W., Graeven, U., Ergun, S., Verago, S., Kilic, N., Stockschlader, M., et al. (1997) "Vascular endothelial growth factor, a possible paracrine growth factor in human acute myeloid leukemia", Blood, 89, 1870–1875.
   Google Scholar
• Bellamy, W.T., Richter, L., Frutiger, Y. and Grogan, T.M. (1999) "Expression of vascular endothelial growth factor and its receptors in hematopoietic malignancies", Cancer Research, 59, 728–733.
   Google Scholar
• Aguayo, A., Estey, E., Kantarjian, H., Mansouri, T., Gidel, C., Keating, M., et al. (1999) "Cellular vascular endothelial growth factor is a predictor of outcome in patients with acute myeloid leukemia", Blood, 94, 3717–3721.
   Google Scholar
• Aguayo, A., O'Brien, S., Keating, M., Manshouri, T., Gidel, C., Barlogie, B., et al. (2000) "Clinical relevance of intracellular vascular endothelial growth factor levels in B-cell chronic lympho-cytic leukemia", Blood, 96, 768–770.
   Google Scholar
• Ferrajoli, A., Manshouri, T., Estrov, Z., Keating, Mi., O'Brien, S., Lerner, S., et al. (2001) "High levels of vascular endothelial growth factor receptor-2 correlate with shortened survival in chronic lymphocytic leukemia", Clinical Cancer Research, 7, 795–799.
   Google Scholar
• Dias, S., Hattori, K., Zhu, Z., Heissig, B., Choy, M., Lane, W., et al. (2000) "Autocrine stimulation of VEGFR-2 activates human leukemia cell growth and migration", Journal of Clinical Investiga-tion, 106, 511–521.
   Google Scholar
• Masood, R., Cai, J., Zheng, T., Smith, DL., Hinton, D.R. and Gill, P.S. (2001) "Vascular endothelial growth factor (VEGF) is an autocrine growth factor for VEGF receptor-positive human tumors", Blood, 98, 1904 — 1913.
   Google Scholar
• Bellamy, W.T., Richter, L., Sirjani, D., Roxas, C., Glinsmann-Gibson, B., Frutiger, Y., et al. (2001) "Vascular endothelial cell growth factor is an autocrine promoter of abnormal localized immature myeloid precursors and leukemia progenitor formation in myelodysplastic syndromes", Blood, 97, 1427 — 1434.
   Google Scholar
• Fusetti, L., Pruneri, G., Gobbi, A., Rabascio, C., Carboni, N., Peccatori, F., et al. (2000) "Human myeloid and lymphoid malignancies in the non-obese diabetic/severe combined immuno-deficiency mouse model: frequency of apoptotic cells in solid tumors and efficiency and speed of engraftment correlate with vascular endothelial growth factor production", Cancer Research, 60, 2527 — 2534.
   Google Scholar
• Oster, W., Cicco, NA., Klein, H., Hirano, T., Kishimoto, T., Lindemann, A., et al. (1989) "Participation of the cytokines interleukin 6, tumor necrosis factor-alpha, and interleukin 1-beta secreted by acute myelogenous leukemia blasts in autocrine and paracrine leukemia growth control", Journal of Clinical Investiga-tion, 84, 451 — 457.
   Google Scholar
• Griffin, JD., Rambaldi, A., Vellenga, E., Young, D.C., Ostapovicz, D. and Cannistra, S. A. (1987) "Secretion of interleukin-1 by acute myeloblastic leukemia cells in vitro induces endothelial cells to secrete colony-stimulating factors", Blood, 70, 1218–1221.
   Google Scholar
• Dankbar, B., Padro, T., Leo, R., Feldmann, B., Kropff, M., Mesters, R.M., et al. (2000) "Vascular endothelial growth factor and interleukin-6 in paracrine tumor-stromal cell interactions in multiple myeloma", Blood, 95, 2630–2636.
   Google Scholar
• Dias, S., Hattori, K., Heissig, B., Zhu, Z., Wu, Y., Witte, L., et al. (2001) "Inhibition of both paracrine and autocrine VEGF/ VEGFR-2 signaling pathways is essential to induce long-term remission of xenotransplanted human leukemias", Proceeding of National Academy of Science USA, 98, 10857–10862.
   Google Scholar
• Fiedler, W., Staib, P., Kuse, R., Duhrsen, U., Flasshove, M., Cavalli, F., et al. (2001) "Role of angiogenesis inhibitors in acute myeloid leukemia", Cancer Journal (Supplement 3), S129— S133.
   Google Scholar
• Bellamy, W.T. (2001) "Expression of vascular endothelial growth factor and its receptors in multiple myeloma and other hemato-poietic malignancies", Seminar in Oncology, 28, 551 — 559.
   Google Scholar
• List, A. (2001) "Vascular endothelial growth factor signaling pathway as an emerging target in hematologic malignancies", The Oncologist, 6, 24–31.
   Google Scholar
• Mesters, R.M., Padro, T., Bicker, R., Steffis, M., Kreuter, M., Goner, M., et al. (2001) "Stable remission after administration of the receptor tyrosine kinase inhibitor SU5416 in a patient with refractory acute myeloid leukemia", Blood, 98, 241 —243.
   Google Scholar
• Smolich, B.D., Yuen, HA., West, K.A., Giles, F.J., Albitar, M. and Cherrington, J.M. (2001) "The antiangiogenic protein kinase inhibitors SU5416 and SU6668 inhibit the SCF receptor (c-kit) in a human myeloid leukemia cell line and in acute myeloid leukemia blasts", Blood, 97, 1413–1421.
   Google Scholar
• Zhu, Z., Rockwell, P., Lu, D., Kotanides, H., Pytowski, B., Hicklin, D.J., et al. (1998) "Inhibition of vascular endothelial growth factor-induced receptor activation with anti-kinase insert domain-contain-ing receptor single-chain antibodies from a phage display library", Cancer Research, 58, 3209–3214.
   Google Scholar
• Zhu, Z., Lu, D., Kotanides, H., Santiago, A., Jimenez, X., Simcox, T., et al. (1999) "Inhibition of vascular endothelial growth factor induced mitogenesis of human endothelial cells by a chimeric anti-kinase insert domain-containing receptor antibody", Cancer Letters, 136, 203 — 213.
   Google Scholar
• Lu, D., Kussie, P., Pytowski, B., Persaud, K., Bohlen, P., Witte, L. and Zhu, Z. (2000) "Identification of the residues in the extracellular region of KDR important for interaction with vascular endothelial growth factor and neutralizing anti-KDR antibodies", Journal of Biological Chemistry, 275, 14321–14330.
   Google Scholar
• Wu, Y., Zhong, Z., Hooper, A., Huber, J., Li, H., Finnerty, B., Bassi, R., et al. (2003) "Monoclonal antibody against VEGFR-1 directly inhibits growth of human breast tumors (abstract)", Proceeding of American Association of Cancer Research, 44, #6340.
   Google Scholar
• Prewett, M., Huber, J., Li, Y., Santiago, A., O'Connor, W., King, K., Overholser, J., et al. (1999) "Antivascular endothelial growth factor receptor (Fetal Liver Kinase 1) monoclonal antibody inhibits tumor angiogenesis and growth of several mouse and human tumors", Cancer Research, 59, 5209 — 5218.
   Google Scholar
• Lu, D., Jimenez, X., Zhang, H., Bohlen, P., Witte, L., and Zhu, Z. (2002) "Selection of high affinity human neutralizing antibodies to VEGFR2 from a large antibody phage display library for antiangiogenesis therapy", International Journal of Cancer, 97, 393— 399.
   Google Scholar
• Zhu, Z., Hattori, K., Jimenez, X., Zhang, H., Ludwig, DL., Dias, S., et al. (2003) "Inhibition of human leukemia in an animal model with human antibodies directed against vascular endothelial growth factor receptor 2. Correlation between antibody affinity and biological activity", Leukemia, 17, 604–611.
   Google Scholar
• Hattori, K., Heissig, B., Wu, Y., Dias, S., Tejada, R., Ferris, B., et al. (2002) "Placenta growth factor reconstitutes hematopoiesis by recruiting VEGFR1 ± stem cells from bone marrow microenviron-ment", Nature Medicine, 8, 841–849.
   Google Scholar
• Luttun, A., Tjwa, M., Moons, L., Wu, Y., Angelillo-Scherrer, A., Liao, F., Nagy, JA., et al. (2002) "Revascularization of ischemic tissues by P1GF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-fltl", Nature Medicine, 8, 831 — 840.
   Google Scholar
• Hiratsuka, S., Maru, Y., Okada, A., Seiki, M., Noda, T., and Shibuya, M. (2001) "Involvement of Flt-1 tyrosine kinase (vascular endothelial growth factor receptor-1) in pathological angiogenesis", Cancer Research, 61, 1207–1213.
   Google Scholar
• Witte, L., Hicklin, DJ., Zhu, Z., Pytowski, B., Kotanides, H., Rockwell, P. and Bohlen, P. (1998) "Monoclonal antibodies targeting the VEGF receptor-2 (Flkl/KDR) as an anti-angiogenic therapeutic strategy", Cancer Metastasis Review, 17, 155–161.
   Google Scholar
• Kim, K.J., Li, B., Winer, J., Armanini, M., Gillett, N., Phillips, H.S., et al. (1993) "Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo", Nature, 362, 841–844.
   Google Scholar
• Kanai, T., Konno, H., Tanaka, T., Baba, M., Matsumoto, K., Nakamura, S., et al. (1998) "Anti-tumor and anti-metastatic effects of human-vascular-endothelial-growth-factor-neutralizing antibody on human colon and gastric carcinoma xenotransplanted orthoto-pically into nude mice", International Journal of Cancer, 77, 933 — 936.
   Google Scholar
• Fong, TA., Shawver, L.K., Sun, L., Tang, C., App, H., Powell, J.T., et al. (1999) "SU5416 is a potent and selective inhibitor of the vascular endothelial growth factor receptor (Flk-1/KDR) that inhibits tyrosine kinase catalysis, tumor vascularization, and growth of multiple tumor types", Cancer Research, 59, 99–106.
   Google Scholar
• Wood, J.M., Bold, G., Buchdunger, E., Cozens, R., Ferrari, S., Frei, J., et al. (2000) "PTK787/ZK 222584, A novel and potent inhibitor of vascular endothelial growth factor receptor tyrosine kinases, impairs vascular endothelial growth factor-induced responses and tumor growth after oral administration", Cancer Research, 60, 2178–2189.
   Google Scholar
• Pavco, P.A., Bouhana, KS., Gallegos, A.M., Agrawal, A., Blanchard, KS., Grimm, S.L., et al. (2000) "Antitumor and antimetastatic activity of ribozymes targeting the messenger RNA of vascular endothelial growth factor receptors", Clinical Cancer Research, 6, 2094–2103.
   Google Scholar
• Gerber, H.P., Malik, AK., Solar, G.P., Sherman, D., Liang, X.H., Meng, G., et al. (2002) "VEGF regulates hemotopoietic stem cell survival by an internal autocrine loop mechanism", Nature, 417, 954— 958.
   Google Scholar
• Ziegler, B.L., Valtieri, M., Porada, GA., De Maria, R., Muller, R., Masella, B., et al. (1999) "KDR receptor: a key marker defining hematopoietic stem cells", Science, 285, 1553–1558.
   Google Scholar
• Lu, D., Jimenez, X., Zhang, H., Wu, Y., Bohlen, P., Witte, L., et al. (2001) "Complete inhibition of vascular endothelial growth factor (VEGF) activities with a bifunctional diabody directed against both VEGF kinase receptors, fms-like tyrosine kinase receptor and kinase insert domain-containing receptor", Cancer Research, 61, 7002–7008.
   Google Scholar
• Baker, C.H., Solorzano, C.C. and Fidler, U. (2002) "Blockade of vascular endothelial growth factor receptor and epidermal growth factor receptor signaling for therapy of metastatic human pancreatic cancer", Cancer Research, 62, 1996–2003.
   Google Scholar
• Kozin, S.V., Boucher, Y., Hicklin, Di., Bohlen, P., Jaffi, R.K. and Suit, H.D. (2001) "Vascular endothelial growth factor receptor-2-blocking antibody potentiates radiation-induced long-term control of human tumor xenografts", Cancer Research, 61, 39–44.
   Google Scholar
• Soker, S., Kaefer, M., Johnson, M., Klagsbrun, M., Atala, A. and Freeman, M. R. (2001) "Vascular endothelial growth factor-mediated autocrine stimulation of prostate tumor cells coincides with progression to a malignant phenotype", American Journal of Pathology, 159, 651 — 659.
   Google Scholar
• Boocock, C.A., Charnock-Jones, D.S., Sharkey, A.M., Mclaren, J., Barker, P.J., Wright, K.A, et al. (1995) "Expression of vascular endothelial growth factor and its receptors lit and kdr in ovarian carcinoma", Journal of the National Cancer Institute, 87, 506–516.
   Google Scholar
• Itakura, J., Ishiwata, T., Shen, B., Kornmann, M. and Korc, M. (2000) "Concomitant over-expression of vascular endothelial growth factor and its receptors in pancreatic cancer", International Journal of Cancer, 85, 27— 34.
   Google Scholar
• Price, D.J., Miralem, T., Jiang, S., Steinberg, R. and Avraham, H. (2001) "Role of vascular endothelial growth factor in the stimula-tion of cellular invasion and signaling of breast cancer cells", Cell Growth and Differentiation, 12, 129–135.
   Google Scholar
• Lacal, P.M., Failla, CM., Pagani, E., Odorisio, T., Schietroma, C., Falcinelli, S., et al. (2000) "Human Melanoma Cells Secrete and Respond to Placenta Growth Factor and Vascular Endothelial Growth Factor", Journal of Investigational Dermatology, 115, 1000–1007.
   Google Scholar